AXIAL THERAPEUTICS, INC. — Form D/A

AXIAL THERAPEUTICS, INC. of WOBURN, MA, a company, filed a Form D amendment with the SEC on 2017-06-29. The offering totals $19.1M, of which $19.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
MICHELLE C DIPPDirectorBOSTON, MA
SARAH K MEIBUSCHDirectorWOBURN, MA
SCOTT C BRUNDirectorWOBURN, MA
REBECCA C SENTERExecutive OfficerWOBURN, MA
NORA C FREYDirectorWOBURN, MA
A. STEWART CAMPBELLDirectorWOBURN, MA
A. STEWART CAMPBELLExecutive OfficerWOBURN, MA
Michele C CuculluDirectorWOBURN, MA
SARKIS K MAZMANIANDirectorWOBURN, MA
JEFFREY E YOUNGExecutive OfficerWOBURN, MA
RICHARD P ALDRICHDirectorWOBURN, MA
MARK K OHORIDirectorWOBURN, MA
JAMES C BLAIRDirectorWOBURN, MA
SAKAE K ASANUMADirectorWOBURN, MA
NORA E FREYDirectorWOBURN, MA
SAKAE C ASANUMADirectorWOBURN, MA
MARK E OHORIDirectorWOBURN, MA
SARAH E MEIBUSCHDirectorWOBURN, MA
RONALD C RENAUD JR.DirectorWOBURN, MA
ERIC C DE LA FORTELLEDirectorWOBURN, MA
JEFFREY C YOUNGExecutive OfficerWALTHAM, MA
Henry C WolfDirectorWALTHAM, MA
David H DonabedianDirectorLexington, MA
David H DonabedianExecutive OfficerLexington, MA

Other filings by this issuer (8)

FiledFormOfferingSold
2025-02-11D$22.0M$19.4M
2023-10-27D$24.0M$11.1M
2021-10-25D/A$37.8M$27.4M
2021-05-26D$20.0M$4.8M
2020-05-22D$8.0M$7.8M
2019-06-24D$10.0M$5.0M
2018-11-21D$28.0M$20.0M
2016-12-07D$19.1M$9.6M

More